
1. j infect dis. 2016 may 1;213(9):1472-5. doi: 10.1093/infdis/jiv752. epub 2015 dec
21.

independent emergence plasmodium falciparum kelch propeller domain mutant 
allele c580y guyana.

chenet sm(1), akinyi okoth s(2), huber cs(1), chandrabose j(3), lucchi nw(1),
talundzic e(2), krishnalall k(3), ceron n(4), musset l(5), macedo de oliveira
a(1), venkatesan m(6), rahman r(7), barnwell jw(1), udhayakumar v(1).

author information: 
(1)malaria branch, division parasitic diseases malaria, center global 
health, centers disease control prevention, atlanta.
(2)malaria branch, division parasitic diseases malaria, center global 
health, centers disease control prevention, atlanta atlanta research 
education foundation, georgia.
(3)guyana ministry health.
(4)pan american health organization-guyana.
(5)laboratoire de parasitologie, world health organization collaborating center
for surveillance antimalarial drug resistance, nrc malaria, institut
pasteur de la guyane, cayenne, french guiana.
(6)president's malaria initiative, us agency international development,
washington d.c.
(7)national malaria program, georgetown, guyana.

suspected artemisinin resistance plasmodium falciparum explored by
examining polymorphisms kelch (pfk13) propeller domain. sequencing of
pfk13 gene resistance markers performed 98 samples guyana. 
five samples carried c580y allele pfk13 propeller domain,
with flanking microsatellite profiles different observed southeast 
asia. molecular data demonstrate independent emergence c580y k13
mutant allele guyana, resistance alleles previously used drugs are
fixed. therefore, guyana neighboring countries, continued molecular
surveillance periodic assessment therapeutic efficacy of
artemisinin-based combination therapy warranted.

Â© author 2015. published oxford university press infectious
diseases society america. rights reserved. permissions, e-mail
journals.permissions@oup.com.

doi: 10.1093/infdis/jiv752 
pmid: 26690347  [indexed medline]

